What You Should Know:
- Endo, a pharmaceutical company, is breaking new ground in healthcare education with the launch of its innovative Spatial Computing Injection Simulator.
- The first-of-its-kind initiative leverages the power of spatial computing, also known as "mixed reality," to create a fully immersive learning environment for healthcare providers using Apple Vision Pro.
XIAFLEX® and the Simulator's Purpose
Endo designed this simulator to help hand specialists
Read More
Pleio Launches OLLIE: AI-Powered Solution to Enhance Human-First Medication Adherence
What You Should Know:
- Pleio, a company known for its human-centric, peer-to-patient platform, has unveiled its latest innovation: OLLIE™.
- The AI-powered solution is designed to deepen patient engagement, empower individuals from the outset of treatment, and establish a strong foundation for lasting behavioral treatment success.
The Problem of Medication Non-Adherence
Medication non-adherence is a pervasive issue in healthcare, with nearly half of all patients
Read More
AI Ambient Scribes Show Promise in Reducing Clinician Burnout, Research Reveals
What You Should Know:
- A new report from the Peterson Health Technology Institute (PHTI) reveals that early adopters of AI-powered "ambient scribe" technology, designed to automate note-taking during patient appointments, are reporting significant potential in reducing clinician burnout. However, the financial impact of these tools remains unclear.
- Ambient scribes utilize artificial intelligence to convert patient-clinician conversations into EMR notes, aiming to alleviate the
Read More
Pharma R&D Returns Surge in 2024, Driven by GLP-1 Therapies, Despite Rising Costs
What You Should Know:
- The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
- This surge, building on 2023’s 4.1%, is largely attributed to the success of GLP-1 therapies, showcasing the lucrative potential of addressing substantial unmet medical needs. However, this positive trend is juxtaposed with rising drug development costs
Read More
Navina Secures $55M to Expand AI-Powered Clinical Intelligence
What You Should Know:
- Navina, a provider of AI-powered clinical intelligence raises $55M in Series C funding round, bringing its total funding to $100M.
- The investment, led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors including Vertex Ventures Israel, Grove Ventures, and ALIVE, will fuel Navina's expansion across the U.S. healthcare market and drive further innovation in its AI technology.
AI-Powered Copilot Delivering
Read More
Roper Technologies to Acquire CentralReach for $1.65B
What You Should Know:
- Roper Technologies has announced a definitive agreement to acquire CentralReach, a provider of autism and intellectual and developmental disabilities (IDD) care software for applied behavior analysis (ABA), multidisciplinary therapy, and special education for $1.65B, which includes a $200M tax benefit resulting from the transaction.
- The acquisition will see Roper Technologies take ownership from global software investor Insight Partners. Roper anticipates
Read More
23andMe Files for Chapter 11 Bankruptcy to Facilitate Sale
What You Should Know:
- 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri.
- The bankruptcy filing is aimed at facilitating a structured sale process to maximize the value of its business. The company has assured its customers that operations will continue as normal and that there will be no changes to the way customer data is stored,
Read More
Mount Sinai Launches NYC’s First Center for AI in Children’s Health
What You Should Know:
- The Icahn School of Medicine at Mount Sinai has unveiled the Center for Artificial Intelligence (AI) in Children’s Health, an initiative that marks New York City’s first dedicated center focused on leveraging AI to transform pediatric healthcare.
- The new center aims to transform children's health outcomes through the development of AI-powered solutions for enhanced diagnostics, personalized treatments, and optimized care delivery for youth and
Read More
Cedars-Sinai Deploys AI-Powered At-Home Scoliosis Monitoring for Pediatric Patients
What You Should Know:
- Cedars-Sinai Spine has launched an innovative pilot program at Cedars-Sinai Guerin Children’s, revolutionizing scoliosis management for pediatric patients by utilizing artificial intelligence (AI) for radiation-free, at-home monitoring and brace compliance tracking.
- The program leverages Momentum Spine, an AI-driven mobile spine-imaging and monitoring platform, a graduate of the Cedars-Sinai Accelerator program. This platform offers a groundbreaking approach
Read More
Operation Warp Speed Leader Tapped as Panther Life Sciences’ New R&D Chief
What You Should Know:
- Panther Life Sciences, a life sciences company specializing in skin-based treatments using microarray patches (MAPs), has announced the appointment of Dr. Matthew Hepburn as Executive Vice President of Research and Development.
- Dr. Hepburn will be instrumental in driving Panther’s strategic vision to commercialize its patented MAP technology, with a focus on delivering the first commercial product to market within the next two years.
- In his new
Read More
